COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2369: Articles 23681-23690  | Next

The Epidemiology Workbench: a Tool for Communities to Strategize in Response to COVID-19 and other Infectious Diseases
Nunez-Corrales, S., Jakobsson, E.
10.1101/2020.07.22.20159798 — Posted: 2020-07-25
Projecting contact matrices in 177 geographical regions: an update and comparison with empirical data for the COVID-19 era
Prem, K., van Zandvoort, K., Klepac, P., Eggo, R. M., Davies, N. G., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, , Cook, A. R., Jit, M.
10.1101/2020.07.22.20159772 — Posted: 2020-07-25 Discussion: Onsite
Estimating Variation of Covid-19 infection in the Population:Results from Understanding Society (UKHLS) first monthly covid-19 survey
Breen, R., Ermisch, J.
10.1101/2020.07.22.20159806 — Posted: 2020-07-25
EPICOVID19: Psychometric assessment and validation of a short diagnostic scale for a rapid Covid-19 screening based on reported symptoms
Bastiani, L., Fortunato, L., Pieroni, S., Bianchi, F., Adorni, F., Prinelli, F., Giacomelli, A., Pagani, G., Maggi, S., Trevisan, C., Noale, M., Jesuthasan, N., Sojic, A., Pettenati, C., Andreoni, M., Antonelli Incalzi, R., Galli, M., Molinaro, S.
10.1101/2020.07.22.20159590 — Posted: 2020-07-25
The role of mathematical model in curbing COVID-19 in Nigeria
Madubueze, C. E., Akabuike, N. U., Sambo, D.
10.1101/2020.07.22.20159210 — Posted: 2020-07-25
Homebound by COVID19: The Benefits and Consequences of Non-Pharmaceutical Intervention Strategies
Oruc Aglar, B. E., Baxter, A., Keskinocak, P., Asplund, J., Serban, N.
10.1101/2020.07.22.20160085 — Posted: 2020-07-24
Effective Contact Tracing for COVID-19: A Systematic Review
Juneau, C.-E., Briand, A.-S., Pueyo, T., Collazzo, P., Potvin, L.
10.1101/2020.07.23.20160234 — Posted: 2020-07-24
Evaluating Scenarios for School Reopening under COVID19
Keskinocak, P., Asplund, J., Serban, N., Oruc Aglar, B. E.
10.1101/2020.07.22.20160036 — Posted: 2020-07-24
Sentiment Informed Timeseries Analyzing AI (SITALA) to curb the spread of COVID-19 in Houston
Desai, P. S.
10.1101/2020.07.22.20159863 — Posted: 2020-07-24
Pediatric intensive care unit admissions for COVID-19: insights using state level data
Loomba, R. S., Villarreal, E. G., Farias, J. S., Bronicki, R. A., Flores, S.
10.1101/2020.07.22.20160226 — Posted: 2020-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).